How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?

Depends who you read.

• ACP: Recommendation 4: ACP recommends against bone density monitoring during the 5-year pharmacologic treatment period for osteoporosis in women. (Grade: weak recommendation; low-quality evidence) [1]
  • Monitoring wasn't addressed in the 2023 update.
• ACR: For adults continuing...